Literature DB >> 25148799

Interleukin-25 Enhances Allergic Inflammation through p38MAPK and NF-κB Pathways in Mouse Models of Allergic Rhinitis.

Zhipeng Li1, Hui Wang2, Lisi Liu3.   

Abstract

Interleukin (IL)-25, a cytokine of IL-17 family, can activate p38 Mitogen-Activated Protein kinases(MAPK) and Nuclear Factor(NF)-κB pathways to propagate Th2 responses. The allergic rhinitis mouse model was established by stimulating BALB/c mouse with ovalbumin (OVA). Then we detected expression of IL-25 and downstream p38MAPK and NF-κB. The expression of IL-25, p38MAPK and NF-κB were detected in the OVA-induced allergic rhinitis mouse model. The allergic parameters, such as allergic symptoms, serum OVA-specific immunoglobulin E (IgE) levels and eosinophil infiltration in the nasal mucosa were compared between OVA group and control group. OVA-induced mice displayed significantly higher allergic responses compared with the saline control group. OVA induced mice demonstrated more allergic symptoms, higher serum OVA-specific IgE levels and eosinophil infiltrations. The increased expression of IL-25, p38MAPK and NF-κB immunoreactivity were detected in epidermal cells in the OVA group. The mRNA measurement of IL-25, p38MAPK and NF-κB showed the same result. IL-25 enhances the OVA-induced allergic rhinitis by activating p38MAPK and NF-κB pathways.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25148799

Source DB:  PubMed          Journal:  Iran J Allergy Asthma Immunol        ISSN: 1735-1502            Impact factor:   1.464


  6 in total

1.  15-Lipoxygenase 1 in nasal polyps promotes CCL26/eotaxin 3 expression through extracellular signal-regulated kinase activation.

Authors:  Zhipeng Li; Ming Zeng; Yanhan Deng; Jinming Zhao; Xiuxia Zhou; John B Trudeau; Ezequiel Goldschmidt; John A Moore; Hongwei Chu; Weitian Zhang; Shankai Yin; Zheng Liu; Y Peter Di; Stella E Lee; Sally E Wenzel
Journal:  J Allergy Clin Immunol       Date:  2019-07-11       Impact factor: 10.793

2.  ILCs and Allergy.

Authors:  Hiroki Kabata; Yasutaka Motomura; Tsuyoshi Kiniwa; Tetsuro Kobayashi; Kazuyo Moro
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  Aurora kinase inhibitor tozasertib suppresses mast cell activation in vitro and in vivo.

Authors:  Li-Na Zhang; Kunmei Ji; Yue-Tong Sun; Yi-Bo Hou; Jia-Jie Chen
Journal:  Br J Pharmacol       Date:  2020-04-06       Impact factor: 8.739

4.  MicroRNAs Involved in Asthma After Mesenchymal Stem Cells Treatment.

Authors:  Guan-Nan Tang; Cheng-Lin Li; Yin Yao; Zhi-Bin Xu; Meng-Xia Deng; Shu-Yue Wang; Yue-Qi Sun; Jian-Bo Shi; Qing-Ling Fu
Journal:  Stem Cells Dev       Date:  2016-06-03       Impact factor: 3.272

5.  IL-25-induced activation of nasal fibroblast and its association with the remodeling of chronic rhinosinusitis with nasal polyposis.

Authors:  Soo-Kyoung Park; Yong-De Jin; Yeong-Kyu Park; Sun-Hee Yeon; Jun Xu; Rui-Ning Han; Ki-Sang Rha; Yong-Min Kim
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

6.  Honeysuckle extract relieves ovalbumin-induced allergic rhinitis by inhibiting AR-induced inflammation and autoimmunity.

Authors:  Bin Lin; Bijuan Cai; Huige Wang
Journal:  Biosci Rep       Date:  2019-07-29       Impact factor: 3.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.